Approval · Notice of Compliance 26893 · 2021
STROMECTOL: Notice of Compliance 26893
Issued October 22, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26893
- Date
- October 22, 2021
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To revise the Product Monograph (PM) with safety updates pertaining to neurological toxicity, including depressed level of consciousness and coma, and to update the PM to the 2020 format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STROMECTOL | Not yet assigned | — |
Medicinal ingredients
- IVERMECTIN 3 MG per TAB